Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulators of cell growth

Progress in Growth Factor Research

Volumn 6, Issue 2-4, 1995, Pages 273-284

  Rajah, Roopa ^a   Katz, Lorraine ^a   Nunn, Steven ^a   Solberg, Paulo ^a   Beers, Tara ^a   Cohen, Pinchas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cathepsins; IGFBP; IGFBP proteases; MMPs; PSA; NGF

Indexed keywords

CATHEPSIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 PROTEASE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 PROTEASE; KALLIKREIN; LEUKOTRIENE D4; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR, GAMMA; PROTEINASE; SERINE PROTEINASE;

ANIMAL; BIOLOGICAL MODEL; CELL DIVISION; CYTOLOGY; DRUG EFFECT; FEMALE; METABOLISM; PHYSIOLOGY; PREGNANCY; REVIEW; SMOOTH MUSCLE;

ANIMALS; CATHEPSINS; CELL DIVISION; ENDOPEPTIDASES; FEMALE; KALLIKREINS; LEUKOTRIENE D4; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; NERVE GROWTH FACTORS; PREGNANCY; SERINE ENDOPEPTIDASES;

EID: 0029433607     PISSN: 09552235     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2235(95)00012-7     Document Type: Article

References (49)

1. Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*
2. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth
3. Insulin-like growth factor axis in prostatic stromal cells from patients with benign prostatic hyperplasia. I
4. 4 on the proliferation of airway smooth muscle cells are mediated by modulation of the IGF axis
5. Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor-I
6. Prostate specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma
7. Biochemical analysis of PSA proteolyzed IGFBP-3
8. 7S nerve growth factor is an insulin-like growth factor-binding protein protease.
9. Acid-activated insulin-like growth-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D
10. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells
11. Cathepsin D is an acid activated IGFBP protease produced in normal and malignant epithelial cells
12. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases
13. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
14. 4 induces MMPs which function as IGFBP-2 protease in airway smooth muscle
15. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
16. Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease
17. Prediction of the three-dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein
18. Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family
19. Clinical significance of IGF binding proteins
20. Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure
21. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperim: effects of a pregnancy-associated serum protease activity
22. Evidence of enzymatic degradation of IGFBPs in the 150 kD complex during pregnancy
23. Neutral and acid IGFBP Proteases in serum from pregnant and nonpregnant adults and patients with prostate cancer
24. Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid
25. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy
26. Tissue inhibitor of metalloproteinases — serum levels during pregnancy and labor term, and preterm
27. Human pregnancy serum contains two distinct IGFBP-3 protease activities: potential role for the plasminogen/plasmin system in IGFBP proteolysis
28. Mechanisms of placental invasion of the uterus and their control
29. Substrate specificities and activation of matrix metaloproteinases
30. In vivo proteolysis of serum IGFBP-3 results in increased availability of IGF to target cells
31. Determination of IGF axis parameters in critically ill neonates
32. Insulin-like growth factor binding-protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity
33. Defects in the GH-IGF-I axis of adults with AIDS wasting and children to fail to thrive
34. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism
35. Growth hormone levels in severe renal failure
36. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid chromatographed uremic serum
37. Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum
38. Insulin-like growth factor binding proteins in growth-retarded children with chronic renal failure
39. Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure
40. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients
41. Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour
42. Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemia
43. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.
44. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways
45. Effect of tissue inhibitor of the matrix metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
46. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts
47. Protease inhibitors of plant origin and role of protease inhibitors in human nutrition
48. Pyrene acts as a cocarcinogen with the carcinogens, benzo[α]pyrene, b-propiolactone and radiation in the induction of malignant transformation of cultured mouse fibroblasts: soybean extract containing the Bowman-Birk inhibitor act as an anticarcinogen
49. The insulin-like growth factor family of peptides, binding proteins and receptors: their potential role in tissue regeneration